MedTrace Logo

Serum Markers as a Bioassay for Unipolar Depression

NCT00825799 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2014-01-03

No results posted yet for this study

Summary

The goal of the study is to validate a biomarker assay for unipolar depression based on serum proteins involved in inflammation, metabolism, and stress response. The study will compare patients with a current major depressive episode to individuals with no history of depression. The hypothesis is that the assay can serve as a diagnostic tool that would be more objective than standard diagnostic questionnaires.

Conditions

Sponsors & Collaborators

  • Ridge Diagnostics Inc.

    collaborator INDUSTRY

  • Steward St. Elizabeth's Medical Center of Boston, Inc.

    lead OTHER

Principal Investigators

  • Michael E. Henry, MD · Steward St. Elizabeth's Medical Center

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00825799 on ClinicalTrials.gov